Department of Haematology, Oslo University Hospital, Oslo, Norway.
Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
Thromb Haemost. 2018 Apr;118(4):664-675. doi: 10.1055/s-0038-1637690. Epub 2018 Apr 4.
Congenital factor (F) VII deficiency is a bleeding disorder caused by a heterogeneous pattern of mutations in the gene. Protein misfolding due to mutations is a strong candidate mechanism to produce the highly represented type I FVII deficiency forms, characterized by a concomitant deficiency of FVII antigen and activity. Misfolded proteins can accumulate within the endoplasmic reticulum (ER) causing ER stress with subsequent activation of the unfolded protein response (UPR). So far, there are limited data on this important issue in FVII deficiency. In this study, we chose as candidate FVII model mutations, the p.Q160R, p.I289del and p.A354V-p.P464Hfs, which are all associated with severe to moderate type I FVII deficiency. In vitro expression of the recombinant (r) mutants rFVII-160R, rFVII-289del or rFVII-354V-464Hfs, which are characterized by either amino acid substitution, deletion, or by an extended carboxyl terminus, demonstrated inefficient secretion of the mutant proteins, probably caused by intracellular retention and association with ER chaperones. Both ER stress and UPR were activated following expression of all FVII mutants, with the highest response for rFVII-289del and rFVII-354V-464Hfs. These data unravel new knowledge on pathogenic mechanisms leading to FVII deficiency, and support the investigation of pharmaceutical modulators of ER stress and UPR as therapeutic agents.
先天性因子 VII 缺乏症是一种出血性疾病,由基因中的杂合突变引起。由于突变导致的蛋白质错误折叠是产生高度代表性的 I 型 FVII 缺乏症形式的强有力候选机制,其特征是同时缺乏 FVII 抗原和活性。错误折叠的蛋白质可以在内质网(ER)内积累,导致 ER 应激,随后激活未折叠蛋白反应(UPR)。迄今为止,关于 FVII 缺乏症的这个重要问题的数据有限。在这项研究中,我们选择了 p.Q160R、p.I289del 和 p.A354V-p.P464Hfs 作为候选 FVII 模型突变,这些突变均与严重至中度 I 型 FVII 缺乏症相关。重组(r)突变体 rFVII-160R、rFVII-289del 或 rFVII-354V-464Hfs 的体外表达,其特征分别为氨基酸取代、缺失或羧基末端延长,表明突变蛋白的分泌效率低下,可能是由于细胞内滞留和与 ER 伴侣结合所致。所有 FVII 突变体表达后均激活了 ER 应激和 UPR,rFVII-289del 和 rFVII-354V-464Hfs 的反应最为强烈。这些数据揭示了导致 FVII 缺乏症的致病机制的新知识,并支持了对 ER 应激和 UPR 的药物调节剂作为治疗剂的研究。